EGFR and cancer: Furthermore, Chen et al. proposed a combined therapeutic approach; they discovered that B7-H3 stabilizes EGFR, thereby mediating cancer cell proliferation, accelerating tumor growth, and contributing to resistance to oxaliplatin (OXP).